This website uses cookies

Cookies are small text files that can be used by websites to make a user's experience more secure and to analyze traffic to the site. We use cookies for the following purposes:

- Necessary: Cookies are required to access secure areas of the website and to provide important platform notifications. The site cannot function properly without these cookies
- Statistics: Cookies are used to track device information anonymously to better understand how visitors interact with the website.

This notice applies to the following domains:

Innovative Clinical Trials

Innovative Clinical Trials 

If you’ve never heard of “umbrella trials” or “platform trials,” you’re not alone. But these terms—used to describe different types of clinical trials—are defining the future of cancer research. These trials allow researchers to study several treatments at once. This is a marked contrast—and a significant advantage over—traditional clinical trials, which are able to test just one drug at a time. For patients with multiple myeloma, these new trial designs offer the prospect of making effective new drugs available more quickly.

With its launch of MyDRUG, the first ever multiple myeloma platform trial, the MMRF is leading the charge in this new research approach. Currently, MyDRUG has six treatment arms studying therapies designed to benefit patients with high-risk multiple myeloma.

This webinar has been developed to provide patients and caregivers with an overview of these new clinical trial types, further details on the MMRF’s groundbreaking MyDRUG study (and other novel clinical trials), and other essential information that will empower them to achieve the best possible outcome for their disease.
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota
Faith E. Davies, MBBCh, MRCP, MD, FRCPath
NYU Langone Health
New York, New York

There is no fee for participating in this webinar. 

Already Registered? Log In Now
Complete this form to register for the webinar.
(* indicates required field)